BACKGROUND & AIMS: Hepatitis C virus (HCV) acquires mutations that allow it to escape the CD8+ T-cell response, although the extent to which this process contributes to viral evolution at the population level is not clear. We studied viral adaptation using data from a large outbreak of HCV genotype 1b infection that occurred among women immunized with contaminated immunoglobulin from 1977 to 1978. METHODS: The HCV nonstructural protein coding regions NS3-NS5B were sequenced from 78 patients, and mutations were mapped according to their location inside or outside previously described CD8+ T-cell epitopes. A statistical approach was developed to identify sites/regions under reproducible selection pressure associated with HLA class I. RESULTS: The frequency of nonsynonymous mutations was significantly higher inside previously described CD8+ T-cell epitopes than outside-particularly in NS3/4A and NS5B. We identified new regions that are under selection pressure, indicating that not all CD8+ T-cell epitopes have been identified; 6 new epitopes that interact with CD8+ T cells were identified and confirmed in vitro. In some CD8+ T-cell epitopes mutations were reproducibly identified in patients that shared the relevant HLA allele, indicating immune pressure at the population level. There was statistical support for selection of mutations in 18 individual epitopes. Interestingly, 14 of these were restricted by HLA-B allele. CONCLUSIONS: HLA class I-associated selection pressure on the nonstructural proteins and here predominantly on NS3/4A and NS5B promotes evolution of HCV. HLA-B alleles have a dominant effect in this selection process. Adaptation of HCV to the CD8+ T-cell response at the population level creates challenges for vaccine design.
BACKGROUND & AIMS: Hepatitis C virus (HCV) acquires mutations that allow it to escape the CD8+ T-cell response, although the extent to which this process contributes to viral evolution at the population level is not clear. We studied viral adaptation using data from a large outbreak of HCV genotype 1b infection that occurred among women immunized with contaminated immunoglobulin from 1977 to 1978. METHODS: The HCV nonstructural protein coding regions NS3-NS5B were sequenced from 78 patients, and mutations were mapped according to their location inside or outside previously described CD8+ T-cell epitopes. A statistical approach was developed to identify sites/regions under reproducible selection pressure associated with HLA class I. RESULTS: The frequency of nonsynonymous mutations was significantly higher inside previously described CD8+ T-cell epitopes than outside-particularly in NS3/4A and NS5B. We identified new regions that are under selection pressure, indicating that not all CD8+ T-cell epitopes have been identified; 6 new epitopes that interact with CD8+ T cells were identified and confirmed in vitro. In some CD8+ T-cell epitopes mutations were reproducibly identified in patients that shared the relevant HLA allele, indicating immune pressure at the population level. There was statistical support for selection of mutations in 18 individual epitopes. Interestingly, 14 of these were restricted by HLA-B allele. CONCLUSIONS: HLA class I-associated selection pressure on the nonstructural proteins and here predominantly on NS3/4A and NS5B promotes evolution of HCV. HLA-B alleles have a dominant effect in this selection process. Adaptation of HCV to the CD8+ T-cell response at the population level creates challenges for vaccine design.
Authors: Andreas Walker; Kathrin Skibbe; Eike Steinmann; Stephanie Pfaender; Thomas Kuntzen; Dominik A Megger; Svenja Groten; Barbara Sitek; Georg M Lauer; Arthur Y Kim; Thomas Pietschmann; Todd M Allen; Joerg Timm Journal: J Virol Date: 2015-10-07 Impact factor: 5.103
Authors: Chaturaka Rodrigo; Preston Leung; Andrew R Lloyd; Rowena A Bull; Fabio Luciani; Jason Grebely; Gregory J Dore; Tanya Applegate; Kimberly Page; Julie Bruneau; Andrea L Cox; William Osburn; Arthur Y Kim; Naglaa H Shoukry; Georg M Lauer; Lisa Maher; Janke Schinkel; Maria Prins; Margaret Hellard; Auda A Eltahla Journal: J Viral Hepat Date: 2019-01-22 Impact factor: 3.728
Authors: Marianne Ruhl; Patrick Chhatwal; Heiko Strathmann; Thomas Kuntzen; Dorothea Bankwitz; Kathrin Skibbe; Andreas Walker; Falko M Heinemann; Peter A Horn; Todd M Allen; Daniel Hoffmann; Thomas Pietschmann; Jörg Timm Journal: J Virol Date: 2011-11-09 Impact factor: 5.103
Authors: Katja Pfafferott; Pooja Deshpande; Elizabeth McKinnon; Shahzma Merani; Andrew Lucas; David Heckerman; Simon Mallal; Mina John; Silvana Gaudieri; Michaela Lucas Journal: PLoS One Date: 2015-06-24 Impact factor: 3.240
Authors: Rowena A Bull; Fabio Luciani; Kerensa McElroy; Silvana Gaudieri; Son T Pham; Abha Chopra; Barbara Cameron; Lisa Maher; Gregory J Dore; Peter A White; Andrew R Lloyd Journal: PLoS Pathog Date: 2011-09-01 Impact factor: 6.823
Authors: Ola Weiland; Gustaf Ahlén; Helmut Diepolder; Maria-Christina Jung; Sepideh Levander; Michael Fons; Iacob Mathiesen; Niranjan Y Sardesai; Anders Vahlne; Lars Frelin; Matti Sällberg Journal: Mol Ther Date: 2013-06-11 Impact factor: 11.454
Authors: Jonathan R Honegger; Seungtaek Kim; Aryn A Price; Jennifer A Kohout; Kevin L McKnight; Mona R Prasad; Stanley M Lemon; Arash Grakoui; Christopher M Walker Journal: Nat Med Date: 2013-10-27 Impact factor: 53.440